Patents by Inventor Zvi Laron

Zvi Laron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating diseases with peptides that inhibit IGF-1
    Patent number: 9657080
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitro cell proliferation and for treatment of various diseases.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: May 23, 2017
    Assignee: Universite Pierre Et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Method of treatment of small for gestational age infants under two years of age
    Patent number: 9168289
    Abstract: The invention provides a method and a composition for the treatment of infants age less than 2.5 years old defined as small for gestational age (SGA), including the use of hGH or any compound that increases blood levels of hGH or of IGF-I. Early use of the composition prevents the irreversible neurological and psychological damage of the children.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: October 27, 2015
    Assignee: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Zvi Laron
  • METHODS FOR TREATING DISEASES WITH PEPTIDES THAT INHIBIT IGF-1
    Publication number: 20150133380
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitro cell proliferation and for treatment of various diseases.
    Type: Application
    Filed: January 30, 2015
    Publication date: May 14, 2015
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • Method for inhibiting growth of chondrocytes in a subject by inhibiting IGF-1
    Patent number: 8975225
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitrocell proliferation and for treatment of various diseases.
    Type: Grant
    Filed: March 19, 2009
    Date of Patent: March 10, 2015
    Assignee: Universite Pierre et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • METHODS FOR INHIBITION OF TYPE 1 DIABETES
    Publication number: 20140370054
    Abstract: This disclosure is directed to methods of inhibiting the development of type 1 diabetes in a subject, including methods of preventing development of type 1 diabetes. The disclosed methods involve pre-partum vaccination of future mothers against rotavirus. Methods of decreasing the prevalence of type 1 diabetes are also disclosed.
    Type: Application
    Filed: June 15, 2014
    Publication date: December 18, 2014
    Inventors: Zvi Laron, Lester Shulman
  • Peptides and uses thereof to modulate IGF-1 synthesis and IGF-1 receptor expression
    Patent number: 8802815
    Abstract: The invention relates to peptides for modulate IGF-1 activity, a pharmaceutical composition comprising them as well as their applications as medicinal products and cell proliferation modulating agents in vitro.
    Type: Grant
    Filed: March 18, 2010
    Date of Patent: August 12, 2014
    Assignee: Universite Pierre et Marie Curie (Paris 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • USE OF HGH FOR THE TREATMENT OF SMALL FOR GESTATIONAL AGE INFANTS UNDER TWO YEARS OF AGE
    Publication number: 20130345132
    Abstract: The invention provides a method and a composition for the treatment of infants age less than 2.5 years old defined as small for gestational age (SGA), including the use of hGH or any compound that increases blood levels of hGH or of IGF-I. Early use of the composition prevents the irreversible neurological and psychological damage of the children.
    Type: Application
    Filed: January 31, 2012
    Publication date: December 26, 2013
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventor: Zvi Laron
  • PEPTIDES MODULATING THE ACTIVITY OF IGF-1 AND THE APPLICATIONS OF SAID PEPTIDES
    Publication number: 20120149640
    Abstract: The invention relates to peptides for modulate IGF-1 activity, a pharmaceutical composition comprising them as well as their applications as medicinal products and cell proliferation modulating agents in vitro.
    Type: Application
    Filed: March 18, 2010
    Publication date: June 14, 2012
    Inventors: Claude Carelli, Zvi Laron, Gila Maor
  • PEPTIDES FOR INHIBITING IGF-1
    Publication number: 20120135926
    Abstract: The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitrocell proliferation and for treatment of various diseases.
    Type: Application
    Filed: March 19, 2009
    Publication date: May 31, 2012
    Applicant: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Claude Carelli, Zvi Laron, Gila Maor